Literature DB >> 9180928

Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.

A de Vries1, C T van Oostrom, P M Dortant, R B Beems, C F van Kreijl, P J Capel, H van Steeg.   

Abstract

Defects in the xeroderma pigmentosum complementation group A-correcting (XPA) gene, which encodes a component of the nucleotide excision repair (NER) pathway, are associated with the cancer-prone human disease xeroderma pigmentosum. We previously generated mice lacking the XPA gene, which develop normally but are highly sensitive to ultraviolet-B and 7,12-dimethylbenz[a] anthracene-induced skin tumors. Here we report that XPA-deficient mice spontaneously developed hepatocellular adenomas at a low frequency as they aged. Furthermore, oral treatment of XPA-deficient mice with the carcinogen benzo[a]pyrene (B[a]P) resulted in the induction of mainly lymphomas. These tumors appeared earlier and with a higher incidence than in B[a]P-treated wild-type and heterozygous mice. Our results show for the first time that XPA-deficient mice also displayed an increased sensitivity to developing tumors other than tumors of the skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180928

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  12 in total

1.  A global collaboration on carcinogenicity screening in transgenic mouse models.

Authors:  R Forster
Journal:  Transgenic Res       Date:  1998-11       Impact factor: 2.788

2.  Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.

Authors:  Jean J Latimer; Vongai J Majekwana; Yashira R Pabón-Padín; Manasi R Pimpley; Stephen G Grant
Journal:  Photochem Photobiol       Date:  2014-12-19       Impact factor: 3.421

3.  Impaired spermatogenesis and elevated spontaneous tumorigenesis in xeroderma pigmentosum group A gene (Xpa)-deficient mice.

Authors:  Hironobu Nakane; Seiichi Hirota; Philip J Brooks; Yusaku Nakabeppu; Yoshimichi Nakatsu; Yoshitake Nishimune; Akihiro Iino; Kiyoji Tanaka
Journal:  DNA Repair (Amst)       Date:  2008-10-01

Review 4.  Hypermutability in carcinogenesis.

Authors:  B S Strauss
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

5.  Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.

Authors:  Y Lu; H Lian; P Sharma; N Schreiber-Agus; R G Russell; L Chin; G T van der Horst; D B Bregman
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Evidence for the involvement of nucleotide excision repair in the removal of abasic sites in yeast.

Authors:  C A Torres-Ramos; R E Johnson; L Prakash; S Prakash
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.

Authors:  Kaarthik John; M Margaret Pratt; Frederick A Beland; Mona I Churchwell; Gail McMullen; Ofelia A Olivero; Igor P Pogribny; Miriam C Poirier
Journal:  Carcinogenesis       Date:  2012-07-24       Impact factor: 4.944

8.  The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.

Authors:  Laura J Niedernhofer; Hanny Odijk; Magda Budzowska; Ellen van Drunen; Alex Maas; Arjan F Theil; Jan de Wit; N G J Jaspers; H Berna Beverloo; Jan H J Hoeijmakers; Roland Kanaar
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Age-associated decreases in human DNA repair capacity: Implications for the skin.

Authors:  I M Hadshiew; M S Eller; B A Gilchrest
Journal:  Age (Omaha)       Date:  1999-04

10.  Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging.

Authors:  J E Cleaver; I Revet
Journal:  Mech Ageing Dev       Date:  2008-02-03       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.